Maverick Ventures
Maverick Ventures describes itself as the venture capital arm of Maverick Capital. Its public materials describe an evergreen fund structure that invests in companies from inception through maturity, with portfolio themes spanning healthcare, consumer, enterprise, and AI-related businesses.
What stands out about Maverick Ventures
Maverick Ventures presents a venture-capital platform with an evergreen investment structure, publicly identified Seed and Early Stage investments, and sector themes including healthcare, software and technology, consumer, enterprise, and AI. Its official publication page does not state a geographic investment mandate or a current universal check-size range.[1][2][3][4]
What does Maverick Ventures invest in?
Maverick Ventures operates through the Maverick Ventures platform associated with Maverick Capital and describes itself as Maverick Capital’s venture capital arm. It states that it partners with entrepreneurs in healthcare, software, and technology.[1][2]
Maverick Ventures describes an evergreen fund structure that allows investment in companies from inception through maturity. This gives the platform a stated investment scope across company development stages rather than a single publicly identified stage.[3]
Owners comparing capital alternatives can review Auxo’s capital advisory services, valuation services, and full-versus-partial sale framework.
What should a business owner evaluate before taking capital from Maverick Ventures?
An owner or founder evaluating Maverick Ventures should clarify how the evergreen structure applies to the company’s stage and proposed financing. The public materials identify Seed and Early Stage investments and an inception-through-maturity approach, but the official Maverick Ventures publication page does not state a current universal check-size range, while the official portfolio page does not disclose valuation thresholds, ownership percentages, or transaction consideration.
Before pursuing a transaction, an owner may also wish to confirm the investing Maverick entity, the applicable fund, governance and information rights, and the terms of any future capital participation.[2][3][4]
How does the evergreen structure affect investment duration or exit expectations
What investment criteria does Maverick Ventures publicly describe?
The official portfolio is organized around healthcare, consumer, enterprise, and AI-related themes. Listed examples include healthcare services, software, cybersecurity, quantum technology, consumer health, and AI businesses.[4]
The official portfolio page labels selected investments as Seed and Early Stage. The official Maverick Ventures publication page does not state a current universal check-size range.[2][4]
The official Maverick Ventures publication page does not state a geographic investment mandate. The sources cited for this profile therefore do not establish whether the platform applies an exclusive or universal geographic scope.[2]
The official portfolio page lists Aligned, Cityblock, Devoted Health, Hims & Hers, Infleqtion, MosaicML, Nourish, Oula, Retool, BioCatch, One Medical, and Io Products as selected Maverick Ventures portfolio companies or investments.[4]
Maverick Ventures stated that it co-led Oula Health’s $28M Series B investment announced February 22, 2024. It also described its partnership with Nourish in connection with Nourish’s $35M Series A announced March 28, 2024.
Its public transaction commentary identifies Docent Health as acquired by GetWellNetwork and Collective Medical as acquired by PointClickCare.[2][3]
What is not clear from Maverick Ventures's public materials?
The official Maverick Ventures portfolio page does not disclose investment amounts, ownership percentages, valuation thresholds, or transaction consideration for the listed companies. The official Maverick Ventures publication page does not state a geographic investment mandate or a current universal check-size range.[2][4]
Questions to ask before taking capital from Maverick Ventures
Which Maverick entity and fund would make the investment?
What current check-size and ownership ranges apply to the company's stage?
How does the evergreen structure affect investment duration or exit expectations?
What governance, board, information, liquidation-preference, and pro-rata rights would apply?
Are there sector, geography, revenue, or traction thresholds not stated publicly?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Investment strategy
- Industry / market focus
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.